Company profile for Levolta Pharmaceuticals

NEW Drugs in Dev: 1
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Levolta Pharmaceuticals is an innovative, clinical-stage pharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of rheumatology, immunology, and cancer. The company is driven to overcome current treatment barriers by developing products with an enhanced therapeutic index that drives customer value. Its lead product, VOLT01, is a ref...
Levolta Pharmaceuticals is an innovative, clinical-stage pharmaceutical company focused on the acquisition, development, and commercialization of medically important pharmaceutical products for the treatment of rheumatology, immunology, and cancer. The company is driven to overcome current treatment barriers by developing products with an enhanced therapeutic index that drives customer value. Its lead product, VOLT01, is a reformulated Zoledronic Acid (ZA) that has demonstrated significantly better safety and efficacy in controlling knee osteoarthritis compared to ZA alone, with the added benefit of no post-dosing symptoms.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
116 Research Dr., Bethlehem, PA 18015
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/levolta-pharmaceuticals-partners-with-tabuk-pharmaceuticals-for-commercialization-of-investigational-osteoarthritis-therapy-in-middle-east-and-africa-301840528.html

PR NEWSWIRE
01 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty